Search Protocols under revision. Back New search Go to resultsDiseaseMain groupSupportive Therapy, ToxicityProtocol groupComplicationsDiseaseCytokine Release SyndromeSubgroupICD10MeSHSequenceAntineoplastic therapySubstanceSubstanceSubstanceSubstanceNo. Substances RadiotherapySupportive therapySubstanceBalanced Crystalloid SolutionTocilizumabSubstanceBalanced Crystalloid SolutionTocilizumabSubstanceBalanced Crystalloid SolutionTocilizumabSubstanceBalanced Crystalloid SolutionTocilizumabNo. Substances2Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationTherapy phaseTherapy intentionRisksEmetogenicity only studiesPublicationAuthorLe RQDiseaseCAR-T-Zell-induziertes Zytokin-Freisetzungs-SyndromOriginCenter for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USAProtocols in Revision 1 protocol foundTocilizumab 8, Cytokine release Syndrome (PID1833 V1.0)
